Lateral Cervical Node Dissection in Differentiated Thyroid Cancer.
Recruiting now · Not applicable
Conditions studied: Thyroid Cancer
In brief
The objective of this study is to compare shoulder and neck morbidity and the effectiveness of cervical lateral nodal dissection in patients with differentiated thyroid cancer and lateral metastases between the anterior and posterior approaches to the sternocleidomastoid muscle (SCM)
Key facts
- Study ID
- NCT06149637
- Run by
- Centro de Excelencia en Enfermedades de Cabeza y Cuello
- People needed
- 62
- Starts
- 2023-08-01
- Expected to finish
- 2028-08-31
- Last updated by the study team
- 2024-10-29
Who can join
Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients ≥ 18 years.
- Patients with macroscopic lymph node involvement identified by physical examination, imaging or intraoperatively in lateral neck.
- Patients with microscopic nodal involvement confirmed by FNAB (definition by the pathologist of suspected or confirmed metastatic papillary carcinoma according to the Bethesda criteria)
- Candidates for lateral lymph node dissection due to suspected or confirmed disease metastatic lymph nodes as defined by the treating surgeon.
- Patients requiring or not requiring thyroidectomy and/or central dissection concomitant with the dissection
You may not qualify if…
- Patients with a history of previous neck dissection
- Histological confirmation of medullary or anaplastic carcinoma
- Previous spinal nerve injury
Where it is running
- Hospital Alma Mater de Antioquia — Medellín, Antioquia, Colombia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.